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Abstract 
oral absorption of cyclosporine was studied in dogs with and 
without bile diversion. Blood and bile cyclosporine concentrations 
were determined by a high pressure liquid chromatographic method. 
The absorption of cyclosporine was signficantly impaired (p < 0.05) 
in dogs with bile diversion. Bile and bile salts appear to be 
essential for the absorption of cyclosporine. 
Introduction 
The use of cyclosporine as an immunosuppressant has resulted in 
improved graft and patient survival following liver, kidney, heart 
and bone marrow transplantation (1-4). However, the various factors 
that influence the pharmacokinetics and pharmacodynamics of 
cyclosporine have not been completely characterized. The kinetics of 
cyclosporine are highly variable between patients and within a 
patient over a time period (5). In particular liver transplant 
patients present a unique challenge in the optimization of 
immunosuppressive therapy with cyclosporine (6). 
Recently, Andrews et al (7) reported significant increases in 
the trough blood cyclosporine concentrations in liver transplant 
patients following clanping of the T-tube inserted into the bile 
duct. A marked reduction in the daily dose of cyclosporine was 
required in order to maintain the desired trough blood concentrations 
in these patients. Since very little unchanged cyclosporine is 
excreted in the bile in liver transplant patients (9), enterohepatic 
recirculation cannot explain the influence of bile diversion on 
cyclosporine blood concentrations. Increased absorption of 
cyclosporine in presence of bile is most likely responsible for such 
an observation. We report the results of a study to quantitate the 
effect of external biliary drainage on cyclosporine absorption in 
dogs. 
Materials and Methods 
Four male mongrel dogs weighing between 17.3 to 24 kg were used 
in this study. The animals were fasted overnight but were allowed 
free access to water at all. times. Food was withheld fran the 
animals for at least 4 hours following drug administration. The dogs 
received 20 mg/kg of cyclosporine (Sandimmune, sandoz Inc., NJ) 
orally on two separate occasions. DUring phase 1 (control) the drug 
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was administered to the dogs with an intact biliarY system. Phase 2 
(biliary diversion) studies were carried out in the same group of 
dogs following the insertion of a cannula into the bile duct to 
exteriorize bile drainage. The dogs were allowed to recover for at 
least 4 days following surgery prior to the second phase of the 
study. Blood s~les were obtained in heparinized tubes at 0, 1, 2, 
3, 4, 6, 8, 10, 12, 16, and 24 hours following drug administration 
during each phase and analyzed for unchanged cyclosporine. 
cyclosporine concentrations in whole blood and bile were 
analyzed by a high pressure liquid chromatographic assay (9). 
Terminal disposition rate constant (A z)' area under the blood 
concentration versus time curve from time a to 24 hours (AUC)~_and 
time 0 to 00 (AUC)~ were calculated according to standard techniques. 
A paired T-test 0 was used to determine the significance of any 
differences in the AUC I S between the two phases. 
Results and Discussion 
Our study design was such that each dog served as its own 
control. The blood concentration versus time profile of cyclosporine 
in dog i4 pre and post bile diversion is shown in figure 1. The 
blood level of cyclosporine during the biliary diversion phase were 
considerably lower when compared to the levels obtained with intact 
biliary system. 
-.. 
Figure 1. Blood cyclosporine concentrations as a function of time 
following oral administration of 20 rng/~g of cyclosporine in dog '4 
with intact bile duct and (0 ) with biliary diversion (b. ). 
The mean (+ S.D) peak blood concentration of 1235 (+325) ng/rnl 
observed during the control phase was significantly (p < 0:05) higher 
compared to the peak concentrations of 273 (+88) ng/rnl following 
biliary diversion. Though the mean time to peak-blood concentrations 
tended to be longer in the dogs with biliary diversion (4.5 hours) 
when conpared to the control dogs (3.0 hours) the differences were 
not statistically significant. The mean (.:t SO) disposition· rate 
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constant of 0.111 (+ 0.027) hours-l during the control phase was not 
significant (p < 0:1)5) from the disposition rate constant of 0.100 
(+ 0.041) during the biliary diversion phase. The harmnic mean half 
lIfe was 6.2 hours in phase 1 and 6.9 hours in phase 2. The mean 
(+ S.D) (AUC)~ was 11293 ±. 2611 ng.hr/ml during the control phase and 
2~43 ±. 734 ng.hr/ml during the bilialf diversion phase. The mean 
(+ S.D) AUC'" was 12679 + 2386 ng'hr ml during control phase and was 
3351 (±. 7559 ng'hr ml-1-during the bile diversion phase (Table I), 
Table 1. 
Effect of Biliary Diversion on cyclosporine Bioavailability in Dogs 
Dog 
(AUC)~ (AUC)~ 
% Relative 
t Dose Control Bile Control Bile Bioavailabilitya 
Diverted Diverted 
(mg) (ng'hr'ml-l ) b c 
1 480 8456 3751 10732 3972 44 37 
2 450 9717 2141 12499 2464 22 24 
3 350 13199 3339 14631 3985 25 27 
4 480 13800 2540 14853 2981 18 20 
Mean 440 11293 2943 12679 3351 27 27 
+ + + + + + + 
S.D. 64 2611 734 2386 755 10 6 
a[AUC (Bile diverted)/AUC (Controll] x 100 
bBased on (AUCl~ values 
~ on (AUC)~ values 
This difference in the AUC between control and the bile diversion 
phase was significant (p < 0.05) and independent of whether AUC""s 
were coopared or the (AUC)A'S were cOIrpared. Less than 1% of ~e 
administered dose of c~closporine is excreted as unchanged 
cyclosporine in the bile in dogs following a dose of 20 mg/kg. The 
similar half lives observed during the two phases and the presence of 
less than 1% of the dose as cyc10sp0rine in the bile indicate that 
the differences in AUC observed are due to differences in the extent 
of absorption of cyclosporine. The relative bioavailability of 
cyclosporine. in the dogs with biliary diversion was 27% when compared 
to the.· control period with intact biliary system. Presence of bile 
results. in approximately threefold increase io the bioavai1abi1ity of 
cyclosporine. 
OUr study indicates that bile is essential for the absorption of 
cyclosporine. Bile has been shown to be necessary for the absorption 
of lipids and lipid soluble conpounds such as vitamins A, D, E, and 
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K, (10) certain macromolecules such as insulin (11), heparin (12), 
and riboflavin (13), and sulfa drugs (14). FUrther studies to 
determine the effect of coadministration of bile salts on 
cyclosporine absorption are currently underway. If exogenous bile 
salts can improve cyclosporine absorption, oral cyclosporine therapy 
can be facilitated in liver transplant patients or in patients who 
malabsorb cyclosporine and the cost of cyclosporine therapy can be 
greatly reduced. 
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